Form 4: USANA Health Sciences Director J Scott Nixon Reports Stock Transaction

J Scott Nixon, a director at USANA Health Sciences, reported the vesting and subsequent acquisition of 490 shares of common stock on April 24, 2024, related to restricted stock units.

Summary

• On April 24, 2024, J Scott Nixon, a director of USANA Health Sciences Inc., reported a transaction involving restricted stock units.
• The transaction involved the vesting of 490 restricted stock units, each representing a contingent right to receive one share of USNA common stock.
• These units vested in accordance with a schedule of 25% on July 24, 2023, October 24, 2023, January 24, 2024, and April 24, 2024.
• Following the transaction, Nixon directly owns 2,886 shares of USANA common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing represents a routine transaction related to previously granted stock units. It doesn't indicate any significant positive or negative outlook.

Positives

• The vesting of restricted stock units indicates that Nixon has met certain performance or time-based requirements set by the company.
• The director's continued holding of 2,886 shares suggests a continued alignment with the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider transactions.

Key Dates